S0202 Gemcit. and Capecit. for Pts w/Unresect Locally Adv Met Gallbladder Cancer or Cholangiocarcinoma

This study is ongoing, but not recruiting participants.

Study NCT00033540 Information provided by Southwest Oncology Group

First Received: April 9, 2002 Last Updated: July 13, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Iqbal S, et al.: SWOG S0202: a phase II trial of gemcitabine and capecitabine in patients (pts) with unresectable or metastatic gallbladder cancer or cholangiocarcinoma. [Abstract] J Clin Oncol 24 (Suppl 18): A-4134, 2006.